The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Globe Investor

News Sources

Take control of your investments with the latest investing news and analysis

Press release from Business Wire

Ironwood Pharmaceuticals to Present at Upcoming Investor Conferences

Tuesday, May 29, 2012

Ironwood Pharmaceuticals to Present at Upcoming Investor Conferences16:00 EDT Tuesday, May 29, 2012 CAMBRIDGE, Mass. (Business Wire) -- Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) will present at the Goldman Sachs 33rd Annual Global Healthcare Conference on Tuesday, June 5, 2012 at 8:40 a.m. Pacific Time (11:40 a.m. Eastern Time) at Terranea Resort in Rancho Palos Verdes, CA. In addition, Ironwood management will also present at the Jefferies 2012 Global Healthcare Conference on Tuesday, June 5, 2012 at 4:00 p.m. Eastern Time at the Grand Hyatt New York. A live webcast of Ironwood's presentations will be accessible through the Investors section of the company's website at To access the webcasts, please log on to the Ironwood website approximately 15 minutes prior to the start time to ensure adequate time for any software downloads that may be required. A replay of the webcasts will be available on Ironwood's website for 14 days following the conference. About Ironwood Pharmaceuticals Ironwood Pharmaceuticals (NASDAQ: IRWD) is an entrepreneurial pharmaceutical company dedicated to the art and science of great drugmaking. Linaclotide, Ironwood's guanylate cyclase-C agonist (GCCA), is an investigational drug for the treatment of irritable bowel syndrome with constipation (IBS-C) and chronic constipation. The efficacy portion of linaclotide's development program has been completed and supports the submitted NDA submission for both indications, as well as the MAA submission in Europe for the IBS-C indication. Ironwood also has a growing pipeline of additional drug candidates in earlier stages of development. Ironwood is located in Cambridge, Mass. To learn more, visit Ironwood Pharmaceuticals, Inc.Corporate Inquiries:Susan Brady, 617-621-8304Corporate Communicationssbrady@ironwoodpharma.comorInvestor Inquiries:Meredith Kaya, 617-374-5082Investor